v3.21.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Revenues $ 6,137 $ 2,318 $ 5,014
Cost of revenues 3,002 1,879 1,659
Gross Profit 3,135 439 3,355
Operating expenses:      
Research and development, net 4,065 4,414 3,877
General, administrative and marketing 4,669 3,656 3,723
Total operating loss 5,599 7,631 4,245
Financial expenses 34 3,303 2,180
Financial income 40    
Exchange differences 181 230 (176)
Financial expenses, net 175 3,533 2,004
Loss for the period 5,774 11,164 6,249
Other comprehensive loss:      
Currency translation differences     (557)
Total comprehensive loss for the period $ 5,774 $ 11,164 $ 6,806
Basic and diluted loss per ordinary share (in Dollars per share) $ 0.84 $ 2.23 $ 1.43
Weighted average number of shares outstanding used in computation of basic and diluted loss per share (in Shares) 6,886,955 4,986,381 4,384,585

Source